PlexusDx vs Ro Body Program: 2026 Membership and Medication Costs

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Ro Body Program bills a clinical membership separately from medication cost—$149 per month for the monthly membership plan, plus medication starting at $149 per month for semaglutide (Wegovy pill) or $299 per month for tirzepatide (Zepbound injection), with higher doses priced up to $299 or $449 respectively (Ro pricing verified September 4, 2026). PlexusDx charges one flat monthly rate that includes medication, provider care, and shipping: $189 per month for semaglutide injection or $289 per month for tirzepatide injection on a month-to-month basis, with lower rates at 3-month ($169 semaglutide, $269 tirzepatide) and 6-month commitments ($149 semaglutide, $249 tirzepatide) (PlexusDx pricing verified September 5, 2026). Over 12 months on the monthly plans at the lowest medication doses, Ro's two-part structure totals $3,576 for semaglutide or $5,376 for tirzepatide; PlexusDx totals $2,268 for semaglutide or $3,468 for tirzepatide (our calculation). Ro offers branded FDA-approved medications; PlexusDx offers compounded versions. Ro provides prepaid membership options that lower the effective monthly membership fee—a $39 introductory first-month rate (standard $149 thereafter), $534 upfront for six months (which is $89 per month), or $888 upfront annually (which is $74 per month)—but medication remains billed separately at dose-dependent rates, and prepaid plans require upfront commitment.

At-a-glance comparison

Breaking down Ro's two-part billing

Ro Body Program separates clinical support from medication cost. The standard monthly membership is $149 per month and covers provider consultations, care coordination, and program access (verified September 4, 2026). Medication is billed separately and varies by drug and dose: the Wegovy pill (semaglutide oral) starts at $149 per month and rises to $299 per month at higher doses; Zepbound injection (tirzepatide) starts at $299 per month and rises to $449 per month (verified September 4, 2026). A member on the lowest semaglutide dose pays $149 membership plus $149 medication—$298 per month total—while a member on the highest semaglutide dose pays $149 membership plus $299 medication—$448 per month total. Tirzepatide members pay $448 to $598 per month total depending on dose (our calculation).

Ro also offers prepaid membership discounts. A $39 introductory first-month membership rate is advertised (standard $149 rate applies from month two onward). A six-month prepaid membership costs $534 upfront, which is $89 per month, and an annual prepaid membership costs $888 upfront, which is $74 per month (both verified September 4, 2026). These prepaid rates lower the membership portion of the monthly bill but do not change the separate medication cost; medication remains billed monthly at the same dose-dependent rates. Prepaid plans require upfront payment and commitment to the full period.

PlexusDx all-in flat pricing

PlexusDx charges a single monthly rate that includes compounded medication, licensed provider consultations, and shipping, with no separate membership fee. On a month-to-month basis, semaglutide injection is $189 per month and tirzepatide injection is $289 per month (verified September 5, 2026). Every dose of a given medication costs the same—there is no price increase when a provider adjusts your dose upward. PlexusDx also offers oral formulations: semaglutide oral capsules are $289 per month and tirzepatide oral capsules are $349 per month on a month-to-month plan, and a microdose GLP-1 injection option is available at $129 per month (verified September 5, 2026).

Committing to a multi-month supply lowers the effective monthly rate. A three-month commitment reduces semaglutide injection to $169 per month and tirzepatide injection to $269 per month; a six-month commitment reduces them further to $149 per month and $249 per month respectively (our calculation from verified pricing, September 5, 2026). Multi-month plans require prepayment for the full period.

12-month cost comparison: semaglutide

We normalize each plan to a 12-month window assuming the lowest available semaglutide dose throughout, which is the best-case scenario for Ro's dose-dependent pricing. All figures are our calculation from verified rates.

PlexusDx's month-to-month semaglutide plan costs $2,268 over 12 months, $1,308 less than Ro's standard monthly plan at $3,576 (our calculation). PlexusDx's six-month commitment at $1,788 annually undercuts every Ro configuration, including Ro's annual prepaid membership at $2,676. Ro's annual prepaid option does offer the lowest total among Ro's plans, saving $900 compared to Ro's standard monthly billing, but it still runs $888 more per year than PlexusDx's six-month plan and requires a $888 upfront membership payment plus ongoing monthly medication charges (our calculation). If a patient's dose increases during the year, Ro's medication cost rises to as much as $299 per month ($3,588 annually for medication alone), widening the gap further; PlexusDx's semaglutide price remains $189, $169, or $149 per month regardless of dose.

12-month cost comparison: tirzepatide

The same pattern holds for tirzepatide, where Ro's dose-dependent medication pricing starts higher and PlexusDx's flat rate remains constant across all doses.

PlexusDx's month-to-month tirzepatide plan totals $3,468 annually, $1,908 less than Ro's standard monthly plan at $5,376 (our calculation). Even Ro's most aggressive prepaid membership—the $888 annual option—leaves a member paying $4,476 over 12 months when combined with the lowest tirzepatide medication rate, still $1,488 more than PlexusDx's month-to-month rate and $1,788 more than PlexusDx's three-month commitment (our calculation). If the member's tirzepatide dose increases to the higher tiers, Ro's medication cost rises to $449 per month ($5,388 annually), pushing the annual total on Ro's prepaid plan to $6,276—more than double PlexusDx's six-month commitment cost of $2,988 (our calculation).

Branded FDA-approved vs compounded medications

Ro Body Program dispenses branded FDA-approved medications: Wegovy, Ozempic (both semaglutide), Zepbound, Mounjaro (both tirzepatide), and Foundayo pill (verified September 4, 2026). These products have completed the FDA's full approval process for safety, efficacy, and manufacturing quality. PlexusDx dispenses compounded semaglutide and tirzepatide—both injection and oral formulations—produced by licensed 503A compounding pharmacies. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

For patients who prefer or require branded medications—because of insurance coverage, confidence in FDA oversight, or clinical guidance—Ro's formulary is the deciding factor, regardless of cost. For patients whose insurance does not cover GLP-1 medications or who are paying out-of-pocket, the cost difference is substantial and compounded options may be appropriate after consultation with a provider.

Service quality and reported member experience

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Ro's aggregate Trustpilot rating was not captured in our research pass (September 4, 2026), but individual Trustpilot and Reddit reports describe friction points including confusion over the separate membership and medication billing structure, delays in prior-authorization processing for insurance claims, difficulty reaching customer service, and reports of weaker-than-expected weight loss results (captured September 4, 2026). One Reddit thread titled "ro_weightloss_meds_are_a_scam" reflects dissatisfaction, though individual anecdotes on Reddit are unverified and may not represent typical outcomes. The two-part billing model—while transparent in Ro's pricing disclosures—has been cited in some reports as a source of surprise or frustration when members see separate line items each month.

These are individual reports and allegations, not verified facts about Ro's overall service quality or clinical effectiveness. Outcomes, side effects, and service experience vary by individual. No provider can guarantee weight loss results, and a licensed clinician's guidance is necessary to determine whether any GLP-1 medication is appropriate and how to manage side effects or adjust treatment over time.

Dose adjustments and long-term cost predictability

PlexusDx's same-price-at-every-dose policy means a patient who starts at a low dose and titrates upward over several months continues paying $189 per month for semaglutide injection (or $169 or $149 on commitment plans) regardless of the final dose level. Ro's dose-dependent pricing means the monthly medication cost can rise from $149 to $299 for semaglutide or from $299 to $449 for tirzepatide as the provider increases the dose (verified September 4, 2026). A patient who remains on a low maintenance dose may see minimal cost variation on Ro's platform, but a patient who progresses to higher doses will see the medication portion of the bill increase by as much as $150 per month. For tirzepatide in particular, where clinical protocols often titrate to higher doses over time, Ro's top-tier medication cost of $449 per month ($5,388 annually) plus membership creates a significantly higher long-term expense than PlexusDx's flat $289 per month ($3,468 annually) or $249 per month on a six-month commitment ($2,988 annually) (our calculation).

Patients who value cost predictability and expect to titrate upward benefit from PlexusDx's flat structure. Patients who anticipate remaining on a low dose throughout treatment and who value branded medications may find Ro's lowest-tier pricing acceptable, particularly if they commit to an annual prepaid membership.

Prepaid commitment trade-offs

Both providers offer prepaid discounts, but the structures differ. PlexusDx's three-month and six-month commitments lower the medication price itself: from $189 to $169 or $149 for semaglutide injection, and from $289 to $269 or $249 for tirzepatide injection. The prepayment covers the full all-in cost—medication, provider care, and shipping—for the commitment period, and the patient receives a lower effective monthly rate with no additional charges during that window.

Ro's prepaid memberships lower the clinical program fee but do not reduce the separate medication cost. The six-month $534 prepaid membership is $89 per month (our calculation), a $60 per month saving versus the $149 standard rate, and the annual $888 prepaid membership is $74 per month (our calculation), a $75 per month saving. However, medication remains billed monthly at full dose-dependent rates. A member on Ro's annual prepaid plan still pays $149 to $299 per month for semaglutide medication or $299 to $449 per month for tirzepatide medication on top of the $888 upfront membership (verified September 4, 2026). The prepaid membership does lower total cost compared to Ro's month-to-month membership, but it requires a large upfront payment and the ongoing medication expense continues to fluctuate with dose.

Patients who prefer to minimize upfront commitment and retain month-to-month flexibility will find PlexusDx's $189 or $289 month-to-month rates more accessible than Ro's combined monthly totals. Patients willing to prepay and who value branded medications may find Ro's annual plan reasonable if they expect to remain on the lowest medication doses, though even in that scenario the 12-month total exceeds PlexusDx's prepaid options (see tables above).

Choose Ro Body Program if…

• You require or strongly prefer branded FDA-approved medications (Wegovy, Ozempic, Zepbound, Mounjaro) rather than compounded formulations.
• Your insurance covers part of the medication cost and you are willing to navigate prior-authorization processes with Ro's support.
• You expect to remain on the lowest available dose throughout treatment and are comfortable with the two-part billing structure.
• You value access to a broad formulary that includes multiple branded options and are prepared to pay a premium for that selection.

Choose PlexusDx if…

• You want one flat monthly rate with no separate membership fee and no price increase when your dose is adjusted upward.
• You are paying out-of-pocket and cost predictability and lower total expense are priorities.
• You are comfortable with compounded semaglutide or tirzepatide after consultation with a licensed provider.
• You prefer month-to-month flexibility at $189 (semaglutide) or $289 (tirzepatide) with the option to commit to multi-month plans for additional savings ($149 and $249 per month on six-month commitments).
• You expect to titrate to higher doses over time and want to avoid dose-dependent price increases.

Methodology and freshness

PlexusDx pricing verified from PlexusDx.com on September 5, 2026. Ro Body Program pricing, membership options, medication formulary, and dose-dependent rate ranges verified from Ro.co on September 4, 2026. PlexusDx Trustpilot rating (4.2 stars, 76% five-star, 81% four-star or higher) captured September 4, 2026. Negative service themes for Ro drawn from individual Trustpilot reviews and Reddit posts captured September 4, 2026; these are individual anecdotes and allegations, not verified facts about typical outcomes or overall service quality. All 12-month cost totals, effective monthly rates from prepaid plans, and combined membership-plus-medication figures are our calculation from the verified rates. Ro's introductory first-month $39 membership rate, six-month $534 prepaid membership, and annual $888 prepaid membership are promotional or prepaid structures; standard ongoing monthly membership is $149 per month. Medication costs at Ro are dose-dependent and billed separately from membership; figures in this article use the lowest and highest observed medication rates per drug. Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Neither PlexusDx nor Ro guarantees eligibility, medication selection, dose, weight loss results, or freedom from side effects; outcomes vary by individual and clinical judgment.

Frequently Asked Questions

Does Ro's membership fee include medication?

No. Ro Body Program bills membership separately from medication. The standard monthly membership is $149 per month (verified September 4, 2026) and covers clinical support and program access; medication is billed as a separate line item starting at $149 per month for semaglutide or $299 per month for tirzepatide, increasing with dose.

Does PlexusDx charge more when my dose increases?

No. PlexusDx charges the same flat monthly rate at every dose of a given medication. Semaglutide injection is $189 per month (or $169 or $149 on commitment plans) regardless of whether you are at the starting dose or a higher maintenance dose (verified September 5, 2026).

What is the real 12-month cost difference between the two providers for semaglutide?

Assuming the lowest semaglutide dose throughout, PlexusDx's month-to-month plan totals $2,268 over 12 months; Ro's standard monthly plan totals $3,576 (our calculation from verified rates). PlexusDx's six-month commitment totals $1,788 annually; Ro's annual prepaid membership plus lowest medication totals $2,676 (our calculation).

Are Ro's medications FDA-approved and PlexusDx's not?

Yes. Ro dispenses branded FDA-approved medications such as Wegovy, Ozempic, Zepbound, and Mounjaro (verified September 4, 2026). PlexusDx dispenses compounded semaglutide and tirzepatide produced by licensed 503A compounding pharmacies. Compounded medications are not FDA-approved, and the FDA does not review them before marketing for safety, effectiveness, or quality.

Can I use insurance with either provider?

Ro supports insurance claims and prior-authorization assistance for its branded medications, though individual Trustpilot and Reddit reports describe delays and friction in that process (captured September 4, 2026). PlexusDx's compounded medications are typically paid out-of-pocket; insurance coverage for compounded GLP-1 drugs is uncommon. A licensed provider or the respective platform's support team can clarify insurance options for your specific plan.

Sources

• PlexusDx.com – pricing, plan structure, medication options (accessed September 5, 2026)
• Ro.co – Ro Body Program membership tiers, medication formulary, dose-dependent pricing (accessed September 4, 2026)
• Trustpilot.com – PlexusDx rating and review distribution (accessed September 4, 2026); individual Ro reviews citing service themes (accessed September 4, 2026)
• Reddit.com – individual user reports on Ro Body Program experience (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.